• Content Count

  • Joined

  • Last visited

  • Days Won


thedestroyerofworlds last won the day on June 6

thedestroyerofworlds had the most liked content!

Community Reputation

2,975 Gaming the system

About thedestroyerofworlds

  • Rank
    Canucks Third-Line
  • Birthday 06/02/1976

Profile Information

  • Gender
  • Location
    In the P dot G dot

Recent Profile Visitors

4,740 profile views
  1. Alberta is now at the point where the actual cost of all those tax cuts that were supposed to pay for themselves with all the promised economic activity trickle down economics fan boys bantered on and on about. Meanwhile, the people who said trickle down economics doesn't work predicted this. How trickle down economics actually works: 1) Cons promise tax cuts and do them. 2) Revenues get destroyed and deficits balloon. 3) Cons use deficits to justify slashing programs, propose privatization to get the books under control. 4) Profit, at least for all the big money donors that is. Alberta is at 3.
  2. There were a number of polls that indicated he would. Shillary was a deeply flawed candidate. The Comey stunt just prior to the elections, and Shillary's flawed campaign taking Michigan, Wisconsin, and Pennsylvania for granted were the ultimate nails in the coffin.
  3. Canada inks deals with Pfizer, Moderna for coronavirus vaccine candidates The Canadian government has signed new deals with pharmaceutical firms Pfizer and Moderna to secure millions of doses in 2021 of the coronavirus vaccine candidates each company is currently developing. Procurement Minister Anita Anand made the announcement on Wednesday morning after Pfizer had tweeted news of the deal shortly before markets opened earlier that day. “We are increasingly focused on the next stage of our recovery, including preparing Canada for mass vaccinations,” said Anand in a press conference, stressing the need to diversify supply chains. “Today we are taking an important step forward.” Pfizer is currently working on four experimental coronavirus vaccines and Moderna is also working on what’s been described as among the leading candidates for a vaccine. Pfizer also last month inked a deal with the U.S. government to supply the first 100 million doses of the vaccine it is developing in December. Anand said the agreements will be for “millions of doses” but didn’t specify an exact amount, adding that the goal is to make sure “Canadians are at the front of the line when a vaccine becomes available.” Any vaccine would still need to be approved by Health Canada before being rolled out. “The contracts reflect the requirement for Health Canada approval, and in particular, once that has occurred, we are expecting deliveries, if all goes well, in 2021,” Anand said. She was pressed several times on why she would not give the amount of vaccine being ordered. Anand said the government is taking an approach that includes both firm orders and also options on purchasing more from suppliers, but said she will wait to share details on doses ordered while negotiations with other suppliers are ongoing. “We are very, very intensely negotiating multiple agreements with multiple suppliers,” she said. “The information on doses will come.” News of the vaccine supply deals comes after Canada’s top doctors on Tuesday cautioned that the restrictions in place to prevent the spread of the virus could need to remain for two or three years, even if a vaccine is found, because it will not be what Dr. Theresa Tam called a “silver bullet.” “We’re going to have to manage this pandemic certainly over the next year, but certainly it may be planning for the longer term on the next two to three years during which the vaccine may play a role,” Tam told reporters. Howard Njoo, deputy chief public health officer, offered similar words of caution. “People might think that if we get a vaccine then everything goes back to normal the way it was before. That’s not the case,” he said. “All of the measures we’ve put in place now will still have to continue with the new reality for quite some time.” Anand said what the top doctors explained was true. “There is not one solution to carry Canadians and the Canadian economy out of the pandemic. Multiple efforts on multiple fronts must be made and followed, and so in terms of the vaccination, that would likely not be mandatory as Dr. Tam has mentioned,” Anand said. “It is an added protection that will hopefully be available to Canadians who are taking monumental efforts now to wear PPE (personal protective equipment), to stay at home, to social distance.” Innovation and Economic Development Minister Navdeep Bains added at the press conference that the government will also be injecting more funding into both vaccine research as well as research into treatments in the form of a new task force. “Until we can immunize all Canadians, we must also focus on treatments for those who contract the virus,” said Bains, adding no decision has been made on whether any vaccine would be mandatory. Bains was asked whether the government is working on a plan for who will get the vaccine first if one does become available. He said those decisions will be made in consultation with provincial and public health leaders. “It’s still early stages. Much of the work is in clinical stages so it’s important we manage expectations,” he said. “This vaccine will not be developed overnight.” Anand said it’s likely vulnerable populations would be at the top of that list.
  4. Made-in-Canada vaccine passes animal testing hurdle, seeks government funding TORONTO -- A Canadian drugmaker says it has produced “compelling” early results from animal testing of a COVID-19 vaccine candidate, but the government hasn’t responded to its application for funding that would allow it to advance to human clinical trials. Calgary-based Providence Therapeutics, which designs cancer drugs using a technique called mRNA, announced Wednesday that the “preclinical” data from testing in mice showed more promising results than other notable COVID-19 research conducted with mRNA vaccines. “I would gladly test our vaccine head-to-head against any out there,” said Chief Scientific Officer Eric Marcusson in a press release. “It is always difficult to compare preclinical results, however, I believe our results compare extremely favorably to preclinical results reported by other companies.” Researchers at the University of Toronto conducted tests on mice and found that the vaccine candidate PTX-COVID19-B produced “robust” neutralizing antibodies, which are needed to defend cells from invading pathogens such as the novel coronavirus. “The results coming from our first animal experiment showed that the vaccines are resulting in a strong immune response,” said Dr. Mario Ostrowski, an immunology professor at the University of Toronto, in a press release. “In particular, the vaccine against the S protein produced neutralizing antibodies at higher titers than the results announced by other mRNA vaccine manufacturers.” Brad Sorenson, president and CEO of Providence Therapeutics, told CTV News that these results show their vaccine has shown to be “equivalent or better” than those from much larger firms in the vaccine race. “We expected that it would work, but the results were even greater than we expected, so we were very pleased about that,” he said. “We're very anxious to repeat this in real-life patients.” Another notable mRNA vaccine is by U.S. biotechnology company Moderna, which has received hundreds of millions in funding from the U.S. government and entered final-stage testing last month when the first of some 30,000 Americans received the shot. But Providence, which says it’s one of Canada’s leading mRNA vaccine producers, hasn’t heard from the government since late May and has yet to receive funding for the next stages of its testing after it submitted a $35-million proposal in April. That same month, the federal government committed more than $600 million to vaccine manufacturing and research in Canada, including clinical trials. Among projects already funded as part of that pledge is a partnership between China’s CanSino Biologics and Dalhousie University in Nova Scotia. Sorenson said his company is expecting to be able to produce 5 million vaccines by next summer, but without help from the federal government, they are hamstrung. “The challenge that we're facing is, we're not a large pharma company,” he said. “We have really good technology, fantastic scientists … but for us to go into human trials, we either need to raise more money -- which we can do if we've got a government that is indicated that they're interested in what we're producing -- or we need a government to sponsor those clinical trials.” Sorenson added that if the Canadian government does not help fund their human trials, they might have to find another government that will. “We're at a point in a company that if the Canadian government doesn't want to do it, we're going to start looking elsewhere, and that's just the reality,” he said. “We've got a world-class vaccine and if it's not going to be for Canadians, it's going to be for somebody else.” Sorenson said he has already had “preliminary discussions” with other governments about their vaccine, primarily from individual provinces. Meanwhile, health professionals and politicians alike are urging the government to speed its funding process for homegrown vaccines so that Canadians won’t have to wait in line for another country’s COVID-19 shot. Among those adding their voice was Alberta Sen. Doug Black, who said pressure should be kept on the government to act. “I see the commitment that's being made by the European and American governments to this identical technology and I'm saying, 'Hmm, why in the name of goodness aren't we pursuing this aggressively in Canada?’” he told The Canadian Press earlier this week. “No stone should be left unturned in pursuit of a made-in-Canada COVID solution.” Industry Canada, which is charge of administering the $600 million to vaccine manufacturing and research in Canada, has not responded to a CTV News request for comment.
  5. Correct on the polling with regards to 2016. There was a lack of polling at the state level in a number of states, especially after the Comey stunt. This time around, there has been a regular emphasis on polling in states. And in many, TRUMP has performed poorly. TRUMP'S path to victory is very narrow and he cannot afford to lose much, especially double digit electoral states. He's been behind for months in Florida. He's behind in Pennsylvania. Texas is surprisingly close. The list of states he won handily that are close or leaning Biden's way does not bode well. Can TRUMP win? Yes. Am I saying Biden is a lock? No. What we are saying is that what won TRUMP the presidency in 2016 doesn't appear to be working for him this time around. He's the incumbent. He has to campaign on his record and what he plans on doing for the next 4 years. His campaign isn't doing that. MAGA. He's had 3 and 1/2 years to MAGA. That, and Biden isn't as disliked as Shillary was. So going negative only opens the door to his faults. And as this thread has shown, there is a lot there.
  6. If you want to sell to Fox News, make sure to photoshop a few gun toting guys for good measure.
  7. If you watch the video, that speculation seems to be highly plausible. You can see what looks like fireworks going off and fires before the large major explosion.
  8. Because they are mostly from 3 groups. Knuckle dragging morons who pray at the TRUMP alter, anti-vaxxers, and pseudo-science homeopathic health nuts.
  9. Every time I read a transcript of one of TRUMP's interviews, I think of this:
  10. Only serious candidates apply. How anyone takes Ye seriously is beyond me. Kanye West withdraws petition to get on NJ’s 2020 ballot
  11. ANd this “Her friend, or boyfriend, was either killed or committed suicide in jail. She’s now in jail,” Trump told Axios’ Jonathan Swan in an interview that aired Monday night on HBO. “Yeah, I wish her well,” he said. “I’d wish you well. I’d wish a lot of people well. Good luck. Let them prove somebody was guilty.” Trump doubles down on well-wishes for alleged sex trafficker Ghislaine Maxwell The president’s remarks come after he drew criticism for his initial reaction to the arrest of Jeffrey Epstein’s longtime companion.